Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of18FDG-PET-CT in Assessing Treatment Response

Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of18FDG-PET-CT in Assessing Treatment Response

We report the case of a 60-year-old woman with metastatic high-grade uterine leiomyosarcoma who achieved a delayed response to second-line therapy with the marine-derived drug trabectedin (Yondelis®, PharmaMar). We used 2-deoxy-2-[18F] fluorodeoxyglucose (FDG)-positron emission tomography (PET-CT) i...

Full description

Bibliographic Details
Main Authors: M.J. Payne, R.E. Macpherson, K.M. Bradley, A.B. Hassan
Format: Article
Language:English
Published: Karger Publishers 2014-02-01
Series:Case Reports in Oncology
Subjects:
Sarcoma
Trabectedin
Delayed response
Uterine leiomyosarcoma
18FDG-PET-CT
Online Access:http://www.karger.com/Article/FullText/355224

Internet

http://www.karger.com/Article/FullText/355224

Similar Items